Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PET/CTbased Radiomics for Lung Cancer (PERL): a Retrospective Multi-center Study

NCT03517306 is registered in ClinicalTrials.gov with Second Affiliated Hospital of Wenzhou Medical University as lead sponsor.

NCT NCT03517306
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03517306 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PET/CTbased Radiomics for Lung Cancer (PERL): a Retrospective Multi-center Study
Lead sponsor
Second Affiliated Hospital of Wenzhou Medical University
Phase
Observational
Overall status
Unknown status
Start date
May 1, 2018
Completion date
September 28, 2019
Enrollment
1,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer